Vimarsana
Biggest News Aggregation in the World

Page 5 - Mark Chin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mark Chin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mark Chin Today - Breaking & Trending Today

Sorriso Pharmaceuticals Launches with $31 Million to Develop Novel Class of Orally Delivered Cytokine Antibodies to Treat Inflammatory Conditions - Vimarsana News

Sorriso Pharmaceuticals Launches with $31 Million to Develop Novel Class of Orally Delivered Cytokine Antibodies to Treat Inflammatory Conditions

/PRNewswire/ -- Sorriso Pharmaceuticals, a company focused on transforming anti-inflammatory antibody therapy, today announced the company has closed on a $31...

Arix Bioscience PLC: Arix Bioscience co-leads USD31 million Series A financing for new portfolio company Sorriso Pharmaceuticals - Vimarsana News

Arix Bioscience PLC: Arix Bioscience co-leads USD31 million Series A financing for new portfolio company Sorriso Pharmaceuticals

DJ Arix Bioscience PLC: Arix Bioscience co-leads USD31 million Series A financing for new portfolio company Sorriso Pharmaceuticals Arix Bioscience PLC (ARIX) Arix Bioscience PLC: Arix Bioscience

Arix Bioscience co-leads $31 million Series A financing for new portfolio company Sorriso Pharmaceuticals - Vimarsana News

Arix Bioscience co-leads $31 million Series A financing for new portfolio company Sorriso Pharmaceuticals

Arix Bioscience co-leads $31 million Series A financing for new portfolio companySorriso Pharmaceuticals Arix announces a new portfolio company, Sorriso, with a 26% ownership stakeSeries A proceeds will enable Sorriso Pharmaceuticals to advance its lead programme, a treatment for IBD, into clinical trialsArix M...

Depixus Raises EUR 30.6M (USD 35.4M) in Series A Financing - Vimarsana News

Depixus Raises EUR 30.6M (USD 35.4M) in Series A Financing

/PRNewswire/ -- Depixus®, a biotechnology company developing a unique technology for the fast, accurate, and straightforward extraction of multiomic...

Depixus Raises EUR 30.6M (USD 35.4M) in Series A Financing - Vimarsana News

Depixus Raises EUR 30.6M (USD 35.4M) in Series A Financing

- The financing will support development of a commercial instrument system based on the company's proprietary and disruptive MAGNA technology. - MAGNA is set to unlock the field of dynamic